adalimumab-ryvk

CHEBI:CHEBI_753063

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

rxcui
2688829
dosage_form
KIT
product_type
HUMAN PRESCRIPTION DRUG
listing_expiration_date
20251231
marketing_start_date
20240731
package_marketing_start_date
20240731
marketing_category
BLA
labeler_name
Quallent Pharmaceuticals Health LLC
manufacturer_name
Quallent Pharmaceuticals Health LLC
generic_name
adalimumab-ryvk
brand_name
Adalimumab-ryvk
brand_name_base
Adalimumab-ryvk
product_ndc
51759-412
application_number
BLA761299
spl_id
024ba97a-674e-4df5-993a-77d6507d9310
package_ndc
51759-412-22
package_description
2 KIT in 1 CARTON (51759-412-22) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .4 mL in 1 SYRINGE (51759-624-31) * .4 mL in 1 POUCH
spl_set_id
dce1590f-9e47-4c4d-9437-cfb18b779a75
upc
0382009156224
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class